» Articles » PMID: 28348076

The Crystal Structure of a Multidomain Protease Inhibitor (HAI-1) Reveals the Mechanism of Its Auto-inhibition

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2017 Mar 29
PMID 28348076
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocyte growth factor activator inhibitor 1 (HAI-1) is a membrane-bound multidomain protein essential to the integrity of the basement membrane during placental development and is also important in maintaining postnatal homeostasis in many tissues. HAI-1 is a Kunitz-type serine protease inhibitor, and soluble fragments of HAI-1 with variable lengths have been identified The full-length extracellular portion of HAI-1 (sHAI-1) shows weaker inhibitory activity toward target proteases than the smaller fragments, suggesting auto-inhibition of HAI-1. However, this possible regulatory mechanism has not yet been evaluated. Here, we solved the crystal structure of sHAI-1 and determined the solution structure by small-angle X-ray scattering. These structural analyses revealed that, despite the presence of long linkers, sHAI-1 exists in a compact conformation in which sHAI-1 active sites in Kunitz domain 1 are sterically blocked by neighboring structural elements. We also found that in the presence of target proteases, sHAI-1 adopts an extended conformation that disables the auto-inhibition effect. Our results also reveal the roles of non-inhibitory domains of this multidomain protein and explain the low activity of the full-length protein. The structural insights gained here improve our understanding of the regulation of HAI-1 inhibitory activities and point to new approaches for better controlling these activities.

Citing Articles

N-glycosylation on Asn-57 is required for the correct HAI-2 protein folding and protease inhibitory activity.

Huang N, Wang Q, Chen C, Hu J, Wang J, Chang P Glycobiology. 2023; 33(3):203-214.

PMID: 36637420 PMC: 10114645. DOI: 10.1093/glycob/cwad002.


Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity.

Chiu Y, Wu Y, Barndt R, Lin Y, Sytwo H, Cheng A Genes Dis. 2022; 9(4):1049-1061.

PMID: 35685459 PMC: 9170578. DOI: 10.1016/j.gendis.2020.12.001.


Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.

Barndt R, Lee M, Huang N, Lu D, Lee S, Du P Hum Mol Genet. 2021; 30(19):1833-1850.

PMID: 34089062 PMC: 8444455. DOI: 10.1093/hmg/ddab150.


Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.

Carroll E, Bailo M, Reihill J, Crilly A, Lockhart J, Litherland G Int J Mol Sci. 2021; 22(11).

PMID: 34072295 PMC: 8199346. DOI: 10.3390/ijms22115817.


Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.

Fuentes-Prior P J Biol Chem. 2020; 296:100135.

PMID: 33268377 PMC: 7834812. DOI: 10.1074/jbc.REV120.015980.


References
1.
Fan B, Wu T, Li W, Kirchhofer D . Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem. 2005; 280(41):34513-20. DOI: 10.1074/jbc.M502119200. View

2.
Szabo R, Sales K, Kosa P, Shylo N, Godiksen S, Hansen K . Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet. 2012; 8(8):e1002937. PMC: 3431340. DOI: 10.1371/journal.pgen.1002937. View

3.
Kojima K, Tsuzuki S, Fushiki T, Inouye K . Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I. J Biochem. 2009; 145(6):783-90. DOI: 10.1093/jb/mvp036. View

4.
Shimomura T, Denda K, Kawaguchi T, Matsumoto K, Miyazawa K, Kitamura N . Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem. 1999; 126(5):821-8. DOI: 10.1093/oxfordjournals.jbchem.a022522. View

5.
Garcia K, Degano M, Pease L, Huang M, Peterson P, Teyton L . Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 1998; 279(5354):1166-72. DOI: 10.1126/science.279.5354.1166. View